Arditi, Chantal
Eicher, Manuela
Junod, Julien
Peytremann-Bridevaux, Isabelle
Funding for this research was provided by:
University of Lausanne
Article History
Received: 15 November 2022
Accepted: 25 September 2023
First Online: 29 September 2023
Declarations
:
: Chantal Arditi, Julien Junod and Isabelle Peytremann-Bridevaux have no conflict of interest to disclose. Manuela Eicher reports grants to her institution from Roche, Kaiku Health, BMS, and personal fees from Roche, BMS, Vifor, Novartis.
: All methods were carried out in accordance with relevant guidelines and regulations. The Ethics Committee on research involving humans of Canton of Vaud (CER-VD), which issues authorization for research involving humans within the scope of the Swiss Law on Human Research, approved the present study (authorization number 2018 − 01345). All study participants provided written informed consent.
: Not applicable.